The impact of HTLV-1 expression on the 3D structure and expression of host chromatin.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
01 Mar 2024
Historique:
received: 29 09 2023
accepted: 12 02 2024
medline: 1 3 2024
pubmed: 1 3 2024
entrez: 1 3 2024
Statut: aheadofprint

Résumé

A typical HTLV-1-infected individual carries >104 different HTLV-1-infected T cell clones, each with a single-copy provirus integrated in a unique genomic site. We previously showed that the HTLV-1 provirus causes aberrant transcription in the flanking host genome and, by binding the chromatin architectural protein CTCF, forms abnormal chromatin loops with the host genome. However, it remained unknown whether these effects were exerted simply by the presence of the provirus or were induced by its transcription. To answer this question, we sorted HTLV-1-infected T-cell clones into cells positive or negative for proviral plus-strand expression, and then quantified host and provirus transcription using RNA-seq, and chromatin looping using quantitative chromosome conformation capture (q4C), in each cell population. We found that proviral plus-strand transcription induces aberrant transcription and splicing in the flanking genome but suppresses aberrant chromatin loop formation with the nearby host chromatin. Reducing provirus-induced host transcription with an inhibitor of transcriptional elongation allows recovery of chromatin loops in the plus-strand-expressing population. We conclude that aberrant host transcription induced by proviral expression causes temporary, reversible disruption of chromatin looping in the vicinity of the provirus.

Identifiants

pubmed: 38427693
doi: 10.1371/journal.ppat.1011716
pii: PPATHOGENS-D-23-01665
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1011716

Informations de copyright

Copyright: © 2024 Yaguchi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Hiroko Yaguchi (H)

Department of Infectious Diseases, Faculty of Medicine, Imperial College London, London, United Kingdom.

Anat Melamed (A)

Department of Infectious Diseases, Faculty of Medicine, Imperial College London, London, United Kingdom.

Saumya Ramanayake (S)

Department of Infectious Diseases, Faculty of Medicine, Imperial College London, London, United Kingdom.

Helen Kiik (H)

Department of Infectious Diseases, Faculty of Medicine, Imperial College London, London, United Kingdom.

Aviva Witkover (A)

Department of Infectious Diseases, Faculty of Medicine, Imperial College London, London, United Kingdom.

Charles R M Bangham (CRM)

Department of Infectious Diseases, Faculty of Medicine, Imperial College London, London, United Kingdom.

Classifications MeSH